Amalgamated Bank Abb Vie Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Amalgamated Bank holds 381,018 shares of ABBV stock, worth $68.6 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

381,018

Previous 366,907 3.85%

Holding current value

$68.6 Million

Previous $62.9 Million 19.56%

% of portfolio

0.62%

Previous 0.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$163.84 - $199.33 $2.31 Million - $2.81 Million	14,111 Added 3.85%	381,018 $75.2 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $2.43 Million - $2.83 Million	-15,679 Reduced 4.1%	366,907 $62.9 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $8.68 Million - $9.89 Million	-54,317 Reduced 12.43%	382,586 $69.7 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $3.45 Million - $3.88 Million	-25,042 Reduced 5.42%	436,903 $67.7 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $4.24 Million - $4.91 Million	-31,737 Reduced 6.43%	461,945 $68.9 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $1.85 Million - $2.31 Million	-13,997 Reduced 2.76%	493,682 $66.5 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $3.54 Million - $4.07 Million	24,454 Added 5.06%	507,679 $80.9 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $1.92 Million - $2.3 Million	-13,849 Reduced 2.79%	483,225 $78.1 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $3.69 Million - $4.23 Million	27,484 Added 5.85%	497,074 $66.7 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $222,944 - $283,435	-1,620 Reduced 0.34%	469,590 $71.9 Million
Q1 2022 Jun 30, 2022	BUY	$131.98 - $163.75 $3.11 Million - $3.86 Million	23,552 Added 5.26%	471,210 $76.4 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $5.75 Million - $7.27 Million	53,506 Added 13.57%	447,658 $60.6 Million
Q3 2021 Oct 29, 2021	SELL	$106.4 - $120.78 $1.85 Million - $2.1 Million	-17,422 Reduced 4.23%	394,152 $42.5 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $32 Million - $35.6 Million	303,888 Added 282.2%	411,574 $46.4 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $518,558 - $570,870	-5,069 Reduced 4.5%	107,686 $11.7 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $47,247 - $63,789	-587 Reduced 0.52%	112,755 $12.1 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $289,516 - $339,797	-3,370 Reduced 2.89%	113,342 $9.93 Million
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $9.66 Million - $12.9 Million	-131,715 Reduced 53.02%	116,712 $11.5 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $505,035 - $765,695	-7,830 Reduced 3.06%	248,427 $18.9 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $725,916 - $908,276	10,064 Added 4.09%	256,257 $22.7 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $3.14 Million - $3.78 Million	49,867 Added 25.4%	246,193 $18.6 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.11 Million - $2.69 Million	-32,057 Reduced 14.04%	196,326 $14.3 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $393,953 - $463,664	5,107 Added 2.29%	228,383 $18.4 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $490,221 - $604,574	-6,297 Reduced 2.74%	223,276 $20.6 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.54 Million - $1.71 Million	-17,298 Reduced 7.01%	229,573 $21.7 Million
Q2 2018 Jul 18, 2018	BUY	$89.78 - $106.23 $1.2 Million - $1.42 Million	13,352 Added 5.72%	246,871 $22.9 Million
Q1 2018 May 22, 2018	BUY	$92.01 - $123.21 $2.1 Million - $2.82 Million	22,873 Added 10.86%	233,519 $22.1 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $1.65 Million - $1.81 Million	18,436 Added 9.59%	210,646 $20.4 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $13.4 Million - $17.1 Million	192,210	192,210 $17.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Abb Vie Inc. Transaction History